Stock Updates

Today’s Top Gainers in the Market BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from Healthcare

Today’s top gainers include the company BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which is in the industry Biotechnology, gaining 9.13% today. In the last week its performance is 1.66%, and -9.55% for the past quarter. Currently, BioMarin Pharmaceutical Inc., BMRN has a target price of 111.95, so today’s gain of 9.13% is a significant step towards its target price. The GAP today is therefore 7.61%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), has a market cap of 12540.1, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 100.00%.

At the current price of 88.19, it has a dividend yield of *TBA, and its target price is 111.95. This is with a profit margin of -20.50%, and total debt/equity of 0.29. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a P/E of *TBA, as well as a forward P/E of *TBA.

With a current EPS of -1.18, and a forecasted EPS growth for next year at 54.00%,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has had a EPS growth for the past five years at -21.30%. For the next five years EPS growth is projected to be 25.00%.

Performance for the year is -42.32%. Since its IPO date on 7/26/1999, the total performance to date is -22.86%.

Volume today for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), is 3619652, while its average volume is 1470.63. Whilst the total gain today was 9.13%, it did have a day high of -4.64%.

Volatility for this week has been at 4.05%, and 4.48% for the month. The 52-week low for BioMarin Pharmaceutical Inc., BMRN has been 41.97%, while the 52-week-high has reached -41.88%.

Looking at its return of investments, which is -4.20%, and its return on assets is -5.20%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has an operating margin of -13.60%. With a sales growth of 16.70% quarter over quarter. Bearing in mind that BioMarin Pharmaceutical Inc., BMRN is in the sector Healthcare, its long-term debt/equity is 0.29, and has a current ratio of 2.6 and 1.8 for quick ratio.

So what is the value of BioMarin Pharmaceutical Inc.? Well its PEG is *TBA, and the P/S is 13.57, along with a P/B of 5.7. Meanwhile it has a p/cash of 27.45.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment